Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

- PMLiVE

Lilly partners with Merus on development of bispecific antibodies for cancer

As part of the deal, Merus could receive a total of up to around $1.6bn for three products

- PMLiVE

WHO’s director-general deems vaccine nationalism a “catastrophic moral failure”

Tedros Adhanom Ghebreyesus warns bilateral deals could threaten COVAX facility

- PMLiVE

Valneva set to begin commercial manufacturing of COVID-19 vaccine within days

Vaccine could be in use in Britain by September

- PMLiVE

Research Partnership appoints Hannah Osborn to MedTech director role

Osborne has previously worked at Ipsos and IQVIA

- PMLiVE

Sourcing R&D innovation: why pharma companies need to evolve their business models

Recent years have seen a significant shift in drug development to specialty areas

- PMLiVE

GSK’s PD-1 inhibitor dostarlimab shows updated promise in dMMR solid tumours

Investigational PD-1 inhibitor is being studied in mismatch repair-deficient solid tumours

2020 – a year to remember or forget?

2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...

Havas Life London

- PMLiVE

NHS is set to begin offering COVID-19 vaccinations to over-70s this week

Announcement comes as ten new vaccination centres open in England

- PMLiVE

Cambridge University develops DNA test for secondary infections in COVID-19 patients

Test can identify cases of ‘ventilator-associated pneumonia’

- PMLiVE

Pfizer, BioNTech temporarily slow down shipments of COVID-19 vaccine to EU

'Temporary' reduction comes as companies bolster production capacity for the year

- PMLiVE

New hire and promotions announced at Evoke KYNE

Karen Urban joins Evoke as a vice president

- PMLiVE

The search for effective drug treatments for COVID-19

PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links